Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 3,252 | 3,813 | 3,811 | 3,610 | 3,002 |
| Operating Income | -3,252 | -3,813 | -3,811 | -3,610 | -3,002 |
| Interest Expense | 2 | 1 | 2 | 4 | 0 |
| Other Income | 0 | 0 | 0 | 0 | -3 |
| Pre-tax Income | -3,254 | -3,814 | -3,814 | -3,613 | -3,005 |
| Net Income Continuous | -3,254 | -3,814 | -3,814 | -3,613 | -3,005 |
| Net Income | $-3,254 | $-3,814 | $-3,814 | $-3,613 | $-3,005 |
| EPS Basic Total Ops | -455,578.30 | -12,606.30 | -13,506.75 | -13,506.75 | -16,208.10 |
| EPS Basic Continuous Ops | -456,269.00 | -12,515.05 | -13,502.23 | -13,192.06 | -15,947.76 |
| EPS Diluted Total Ops | -455,578.30 | -12,606.30 | -13,506.75 | -13,506.75 | -16,208.10 |
| EPS Diluted Continuous Ops | -456,269.00 | -12,515.05 | -13,502.23 | -13,192.06 | -15,947.76 |
| EBITDA(a) | $-3,248 | $-3,810 | $-3,808 | $-3,607 | $-2,999 |